128 related articles for article (PubMed ID: 15294293)
21. Benzothiazole based inhibitors of p38alpha MAP kinase.
Liu C; Lin J; Pitt S; Zhang RF; Sack JS; Kiefer SE; Kish K; Doweyko AM; Zhang H; Marathe PH; Trzaskos J; Mckinnon M; Dodd JH; Barrish JC; Schieven GL; Leftheris K
Bioorg Med Chem Lett; 2008 Mar; 18(6):1874-9. PubMed ID: 18296051
[TBL] [Abstract][Full Text] [Related]
22. Crystal structure of the p38α MAP kinase in complex with a docking peptide from TAB1.
Xin F; Wu J
Sci China Life Sci; 2013 Jul; 56(7):653-60. PubMed ID: 23722236
[TBL] [Abstract][Full Text] [Related]
23. Structural bioinformatics-based prediction of exceptional selectivity of p38 MAP kinase inhibitor PH-797804.
Xing L; Shieh HS; Selness SR; Devraj RV; Walker JK; Devadas B; Hope HR; Compton RP; Schindler JF; Hirsch JL; Benson AG; Kurumbail RG; Stegeman RA; Williams JM; Broadus RM; Walden Z; Monahan JB
Biochemistry; 2009 Jul; 48(27):6402-11. PubMed ID: 19496616
[TBL] [Abstract][Full Text] [Related]
24. p38alpha mitogen-activated protein kinase inhibitors: optimization of a series of biphenylamides to give a molecule suitable for clinical progression.
Aston NM; Bamborough P; Buckton JB; Edwards CD; Holmes DS; Jones KL; Patel VK; Smee PA; Somers DO; Vitulli G; Walker AL
J Med Chem; 2009 Oct; 52(20):6257-69. PubMed ID: 19772287
[TBL] [Abstract][Full Text] [Related]
25. Expression and purification of active PKB kinase from Escherichia coli.
Klein S; Geiger T; Linchevski I; Lebendiker M; Itkin A; Assayag K; Levitzki A
Protein Expr Purif; 2005 May; 41(1):162-9. PubMed ID: 15802234
[TBL] [Abstract][Full Text] [Related]
26. Two methods for improved purification of full-length mammalian proteins that have poor expression and/or solubility using standard Escherichia coli procedures.
Geng J; Carstens RP
Protein Expr Purif; 2006 Jul; 48(1):142-50. PubMed ID: 16529945
[TBL] [Abstract][Full Text] [Related]
27. Chaperone over-expression in Escherichia coli: apparent increased yields of soluble recombinant protein kinases are due mainly to soluble aggregates.
Haacke A; Fendrich G; Ramage P; Geiser M
Protein Expr Purif; 2009 Apr; 64(2):185-93. PubMed ID: 19038347
[TBL] [Abstract][Full Text] [Related]
28. A new approach on the purification of recombinant human soluble catechol-O-methyltransferase from an Escherichia coli extract using hydrophobic interaction chromatography.
Passarinha LA; Bonifácio MJ; Soares-da-Silva P; Queiroz JA
J Chromatogr A; 2008 Jan; 1177(2):287-96. PubMed ID: 17588591
[TBL] [Abstract][Full Text] [Related]
29. Nuclear protein NP60 regulates p38 MAPK activity.
Fu J; Yang Z; Wei J; Han J; Gu J
J Cell Sci; 2006 Jan; 119(Pt 1):115-23. PubMed ID: 16352664
[TBL] [Abstract][Full Text] [Related]
30. p38alpha and p38delta mitogen-activated protein kinase isoforms regulate invasion and growth of head and neck squamous carcinoma cells.
Junttila MR; Ala-Aho R; Jokilehto T; Peltonen J; Kallajoki M; Grenman R; Jaakkola P; Westermarck J; Kähäri VM
Oncogene; 2007 Aug; 26(36):5267-79. PubMed ID: 17334397
[TBL] [Abstract][Full Text] [Related]
31. Expression and purification of the synthetic preS1 gene of Hepatitis B Virus with preferred Escherichia coli codon preference.
Qian B; Shen H; Xiong J; Chen L; Zhang L; Jia J; Wang Y; Zhang Z; Yuan Z; Cao K; Zhang D
Protein Expr Purif; 2006 Jul; 48(1):74-80. PubMed ID: 16439156
[TBL] [Abstract][Full Text] [Related]
32. p38 MAP kinase inhibitors: many are made, but few are chosen.
Dominguez C; Powers DA; Tamayo N
Curr Opin Drug Discov Devel; 2005 Jul; 8(4):421-30. PubMed ID: 16022178
[TBL] [Abstract][Full Text] [Related]
33. Structures of p38alpha active mutants reveal conformational changes in L16 loop that induce autophosphorylation and activation.
Diskin R; Lebendiker M; Engelberg D; Livnah O
J Mol Biol; 2007 Jan; 365(1):66-76. PubMed ID: 17059827
[TBL] [Abstract][Full Text] [Related]
34. p38α MAP kinase phosphorylates RCAN1 and regulates its interaction with calcineurin.
Ma L; Tang H; Ren Y; Deng H; Wu J; Wang Z
Sci China Life Sci; 2012 Jul; 55(7):559-66. PubMed ID: 22864830
[TBL] [Abstract][Full Text] [Related]
35. Design, synthesis, and anti-inflammatory properties of orally active 4-(phenylamino)-pyrrolo[2,1-f][1,2,4]triazine p38alpha mitogen-activated protein kinase inhibitors.
Hynes J; Dyckman AJ; Lin S; Wrobleski ST; Wu H; Gillooly KM; Kanner SB; Lonial H; Loo D; McIntyre KW; Pitt S; Shen DR; Shuster DJ; Yang X; Zhang R; Behnia K; Zhang H; Marathe PH; Doweyko AM; Tokarski JS; Sack JS; Pokross M; Kiefer SE; Newitt JA; Barrish JC; Dodd J; Schieven GL; Leftheris K
J Med Chem; 2008 Jan; 51(1):4-16. PubMed ID: 18072718
[TBL] [Abstract][Full Text] [Related]
36. Expression optimization and purification process development of an engineered soluble recombinant mouse linker of activation of T cells using surface enhanced laser desorption/ionization-mass spectrometry.
Brenac V; Mouz N; Schapman A; Ravault V
Protein Expr Purif; 2006 Jun; 47(2):533-41. PubMed ID: 16600631
[TBL] [Abstract][Full Text] [Related]
37. A step-wise approach significantly enhances protein yield of a rationally-designed agonist antibody fragment in E. coli.
Lin B; Renshaw MW; Autote K; Smith LM; Calveley P; Bowdish KS; Frederickson S
Protein Expr Purif; 2008 May; 59(1):55-63. PubMed ID: 18314349
[TBL] [Abstract][Full Text] [Related]
38. NMR spectroscopic investigations of the activated p38α mitogen-activated protein kinase.
Nielsen G; Schwalbe H
Chembiochem; 2011 Nov; 12(17):2599-607. PubMed ID: 22012687
[TBL] [Abstract][Full Text] [Related]
39. Structure of MAPKs.
Goldsmith EJ; Cobb MH; Chang CI
Methods Mol Biol; 2004; 250():127-44. PubMed ID: 14755085
[No Abstract] [Full Text] [Related]
40. Discovery of 4-(5-(cyclopropylcarbamoyl)-2-methylphenylamino)-5-methyl-N-propylpyrrolo[1,2-f][1,2,4]triazine-6-carboxamide (BMS-582949), a clinical p38α MAP kinase inhibitor for the treatment of inflammatory diseases.
Liu C; Lin J; Wrobleski ST; Lin S; Hynes J; Wu H; Dyckman AJ; Li T; Wityak J; Gillooly KM; Pitt S; Shen DR; Zhang RF; McIntyre KW; Salter-Cid L; Shuster DJ; Zhang H; Marathe PH; Doweyko AM; Sack JS; Kiefer SE; Kish KF; Newitt JA; McKinnon M; Dodd JH; Barrish JC; Schieven GL; Leftheris K
J Med Chem; 2010 Sep; 53(18):6629-39. PubMed ID: 20804198
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
